See also this year's filing and all EDGAR filings for this company.
PDF Report 0001610820_2023_BriaCell_Therapeutics_Corp.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001610820', 'EntityCommonStockSharesOutstanding': 15518018, 'Assets': 42577041, 'AssetsCurrent': 42346700, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 230339, 'Liabilities': 32248109, 'LiabilitiesAndStockholdersEquity': 42577041, 'LiabilitiesCurrent': 941087, 'LiabilitiesNoncurrent': 31307022, 'NetIncome': -26838903, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 2, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 10328932, 'remainder_NetIncome': -26838903, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001610820')"} |
Edgar->Model Mapping
